SERUM AND CSF DRUG LEVELS AND D2 OCCUPANCY FOR PALIPERIDONE AND RISPERIDONE

帕利哌酮和利培酮的血清和脑脊液药物水平以及 D2 占用率

• 批准号: 8357465
• 负责人: Emil CHRIS MULY
• 金额: $ 4.12万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8357465
• 关键词: Chronic; Dopamine Receptor; Funding; Grant; Infusion procedures; Manuscripts; Methods; National Center for Research Resources; Paper; Pharmaceutical Preparations; Primates; Principal Investigator; Publications; Publishing; Research; Research Infrastructure; Resources; Risperidone; Serum; Source; United States National Institutes of Health; cost; receptor binding

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. This project has been completed. Our paper describing our method of chronic intragastric infusion has been published. Our findings on the dopamine receptor binding of these drugs have been submitted for publication and a revised manuscript is being prepared.

该副本是利用资源的众多研究子项目之一 由NIH/NCRR资助的中心赠款提供。对该子弹的主要支持 而且，副投影的主要研究员可能是其他来源提供的 包括其他NIH来源。 列出的总费用可能 代表subproject使用的中心基础架构的估计量， NCRR赠款不直接向子弹或副本人员提供的直接资金。 该项目已经完成。 我们描述了慢性胃内输注方法的论文已发表。 我们对这些药物的多巴胺受体结合的发现已提交出版，并正在准备修订的手稿。